Evidence map›Paper›PMID 16618806›Full record

ArticleGenes & development2006

Two-stage mechanism for activation of the DNA replication checkpoint kinase Cds1 in fission yeast.

Yong-jie Xu, Matthew Davenport, Thomas J Kelly

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Smc5/6 Complex Promotes Rad3Molecular and cellular biology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. RecQ DNA Helicase Rqh1 Promotes Rad3Molecular and cellular biology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. AMolecular and cellular biology · 2019
    Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yong-jie XuProgram in Molecular Biology, Sloan-Kettering Institute, New York, New York 10021, USA.
Matthew Davenport
Thomas J Kelly
Memorial Sloan Kettering Cancer Center · USKettering University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DNA replication checkpoint is a complex signal transduction pathway, present in all eukaryotic cells, that functions to maintain genomic integrity and cell viability when DNA replication is perturbed. In Schizosaccharomyces pombe the major effector of the replication checkpoint is the protein kinase Cds1. Activation of Cds1 is known to require the upstream kinase Rad3 and the mediator Mrc1, but the biochemical mechanism of activation is not well understood. We report that the replication checkpoint is activated in two stages. In the first stage, Mrc1 recruits Cds1 to stalled replication forks by interactions between the FHA domain of Cds1 and specific phosphorylated Rad3 consensus sites in Mrc1. Cds1 is then primed for activation by Rad3-dependent phosphorylation. In the second stage, primed Cds1 molecules dimerize via phospho-specific interactions mediated by the FHA domains and are activated by autophosphorylation. This two-stage activation mechanism for the replication checkpoint allows for rapid activation with a high signal-to-noise ratio.

Indexed as

Catalytic DomainCell Cycle ProteinsCheckpoint Kinase 2DimerizationEnzyme ActivationFungal ProteinsPhosphorylationProtein KinasesProtein Serine-Threonine KinasesSchizosaccharomycesSchizosaccharomyces pombe ProteinsCds1 protein, S pombeCell Cycle ProteinsCheckpoint Kinase 2Fungal ProteinsProtein KinasesProtein Serine-Threonine Kinasesrad3 protein, S pombeSchizosaccharomyces pombe Proteinstel1 protein, S pombe

Identifiers

PMID16618806
PMCPMC1472306
OpenAlexW2129353954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.